• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PracSys wins accelerator supply deal

Article

PracSys of Salem, NH, has signed an agreement with North American Scientific to construct two linear accelerator systems for isotope production. North American Scientific, of North Hollywood, CA, will pay PracSys $2.7 million for the accelerators, which

PracSys of Salem, NH, has signed an agreement with North American Scientific to construct two linear accelerator systems for isotope production. North American Scientific, of North Hollywood, CA, will pay PracSys $2.7 million for the accelerators, which are expected to be online by the end of this year.

PracSys has developed a type of accelerator based on nested high-voltage generator (NHVG) technology. The company hopes the NHVG design will prove to be a more economical alternative to cyclotrons for producing medical radioisotopes (SCAN 9/11/96). North American Scientific said it pursued the deal to give the company a reliable supply of radioisotopes as it focuses its development efforts in the areas of brachytherapy and other therapeutic applications.

In other North American Scientific news, the company reported that it has received clearance to have its stock listed on the NASDAQ National Market System. The company's stock will trade under the symbol "NASI."

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.